Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	4382.29	2915.95	65.05
Graham Fair Price	-86.71	1.22	9.15
PEG	2657.61	-15.95	0.58
Price/Book	9.37	1.60	1.46
Price/Cash Flow	-187.29	-452.75	-157.59
Prices/Earnings	5918.76	1522.97	25.30
Price/Sales	29.81	27.43	21.13
Price/FCF	-187.29	-452.75	-157.59
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	-10.41	0.51	0.57
Operating Margin	-96.05	-0.01	0.29
ROA	-98.18	< 0.005	0.01
ROE	0.01	< 0.005	-98.18
ROIC	0.01	< 0.005	-96.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.23	-0.24	6.24
Dividends QOQ	-0.54	-1.00	-83.72
EBIT QOQ	0.61	-1.11	82.15
EPS QOQ	0.44	-0.95	118.26
FCF QOQ	-1.25	-1.16	7.75
Revenue QOQ	-0.47	-0.05	89.68
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	741.96	893.09	20.37
Days Sales Outstanding (DSO)	84.04	67.59	-19.58
Inventory Turnover	0.12	0.10	-16.92
Debt/Capitalization	0.04	0.03	-11.91
Quick Ratio	1.77	1.52	-14.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	16.05	16.04	-0.08
Cash	3.01	2.44	-18.90
Capex	-0.05	0.02	-53.46
Free Cash Flow	-0.15	-0.06	62.48
Revenue	1.11	0.92	-16.95
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	3.61	3.60	-0.36
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.85	-233.35	-3308.03
Naive Interpretation	Member

06 - Financial Health · Bad

Rating